Evidence map›Paper›PMID 39892206›Full record

ArticlePsychoneuroendocrinology2025

PACAP associated with precise PTSD and fear extinction response in women.

Shane W Adams, Thomas C Neylan, Victor May, Sayamwong E Hammack, Kerry Ressler, Sabra S Inslicht

Abstract read
In one paragraph

Article in Psychoneuroendocrinology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Lateral septal PACAP signaling regulates stress and anxiety reactions.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2026
    Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Shane W AdamsDepartment of Neurosurgery, Stanford University School of Medicine, Palo Alto, CA, USA; Polytrauma System of Care, VA Palo Alto Health Care System, Palo Alto, CA, USA; VA San Francisco Medical Center, San Francisco, CA, USA. Electronic address: shane.adams@va.gov.
Thomas C NeylanVA San Francisco Medical Center, San Francisco, CA, USA; Weill Institute for Neurosciences, Department of Psychiatry and Behavioral Sciences, University of California, San Francisco, San Francisco, CA, USA.
Victor MayLarner College of Medicine, University of Vermont, Burlington, VT, USA.
Sayamwong E HammackDepartment of Psychological Sciences, University of Vermont, Burlington, VT, USA.
Kerry ResslerDivision of Depression and Anxiety Disorders, McLean Hospital, Belmont, MA, USA; Department of Psychiatry, Harvard Medical School, Boston, MA, USA.
Sabra S InslichtVA San Francisco Medical Center, San Francisco, CA, USA; Weill Institute for Neurosciences, Department of Psychiatry and Behavioral Sciences, University of California, San Francisco, San Francisco, CA, USA. Electronic address: sabra.inslicht@ucsf.edu.

Funding

CTSA: K12 COMPONENTKL2RR024130 · NCRR · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI JOHNSTON, S. CLAIBORNE · 2006 to 2011
$19.3M
Clinical Features and Neuropathological Basis of Sleep Wake Behavior in Alzheimer's and PSPR01AG060477 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Lea Tenenholz Grinberg, Thomas C Neylan · 2019 to 2026
$8.2M
Investigating Fear System Myelination in PTSD Using In Vivo and Post Mortem DataR01MH132617 · NIMH · NORTHERN CALIFORNIA INSTITUTE/RES/EDU · PI HUBER, BERTRAND R, NEYLAN, THOMAS C · 2023 to 2025
$2.1M
CSRD VA I01 CX000720NCRR NIH HHS KL2 RR024130NIA NIH HHS R01 AG060477NIMH NIH HHS R01 MH132617
6 · The paper itself

Abstract

Behavioral, biological, and physiological reactions following posttraumatic stress disorder (PTSD) are heterogeneous, particularly between sexes. Pituitary adenylate cyclase-activating polypeptide (PACAP38) is identified as a viable sex-specific marker of PTSD and fear conditioning impairments in women. However, no studies have examined the association between PACAP38 and fear extinction in humans to inform treatment mechanisms, and the association between PACAP38 and PTSD is variable, requiring further investigation. Participants (n = 123) included representative proportions of women (48.8 %), those with ≥subthreshold PTSD (39.8 %), veterans (33.3 %), and participants of color (59.5 %). Main outcomes and measures included PTSD symptoms (CAPS-IV), peripheral serum PACAP38, differential skin conductance response during a fear conditioning paradigm. The Middle-Out Approach was applied to integrate behavioral, biological, and physiological indicators and identify precise clinical phenotypes using latent class analysis. The current study provides behavioral, biological, and physiological evidence of a homogeneous subgroup (13.8 %), composed largely of women, for whom peripheral PACAP38 levels were over twofold higher than other participants (η

Indexed as

Extinction, PsychologicalFearPituitary Adenylate Cyclase-Activating PolypeptideStress Disorders, Post-TraumaticAdultConditioning, ClassicalConditioning, PsychologicalFemaleGalvanic Skin ResponseHumansMaleMiddle AgedVeteransPituitary Adenylate Cyclase-Activating PolypeptideFear ConditioningIntegrativePACAPPhysiologicalPrecisionPTSDWomen

Identifiers

PMID39892206
PMCPMC12994156

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.